CoChat

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

Open access

The DOI matches its Crossref record; 273 of the 274 references it cites were found in a registry or an index.

Abstract

Studies of psychiatric disorders have traditionally focused on emotional symptoms such as depression, anxiety and hallucinations. However, poorly controlled cognitive deficits are equally prominent and severely compromise quality of life, including social and professional integration. Consequently, intensive efforts are being made to characterize the cellular and cerebral circuits underpinning cognitive function, define the nature and causes of cognitive impairment in psychiatric disorders and identify more effective treatments. Successful development will depend on rigorous validation in animal models as well as in patients, including measures of real-world cognitive functioning. This article critically discusses these issues, highlighting the challenges and opportunities for improving cognition in individuals suffering from psychiatric disorders.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrd3628

Cites

273 of 273 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 273 references

Cited by

Items 401–500 of 1,001

Metadata

Authors
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., Dubois, B., Geyer, M. A., Goodwin, G. M., Gorwood, P., Jay, T. M., Joëls, M., Mansuy, I. M., Meyer-Lindenberg, A., Murphy, D., Rolls, E., Saletu, B., Spedding, M., Sweeney, J., Whittington, M., & Young, L. J.
Affiliations
  • Institut de Recherches Internationales Servier (France) (FR)
  • Pitié-Salpêtrière Hospital (FR)
  • University Hospitals of the Ruhr-University of Bochum (DE)
  • University of Cambridge (GB)
  • University of California, Davis (US)
  • University of Massachusetts Dartmouth (US)
  • Université Paris-Sud (FR)
  • University of Pennsylvania (US)
  • Institut du Cerveau (FR)
  • University of California San Diego (US)
  • Warneford Hospital (GB)
  • Inserm (FR)
  • University Medical Center Utrecht (NL)
  • University of Zurich (CH)
  • King's College London (GB)
  • University of Warwick (GB)
  • Medical University of Vienna (AT)
  • Servier (France) (FR)
  • The University of Texas Southwestern Medical Center (US)
  • Newcastle University (GB)
  • Emory University (US)
Corresponding author
Millan, Mark J.
Venue
Nature Reviews Drug Discovery
Published
2012-02
Volume
11
Issue
2
Pages
141-168
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W2080092700
Cited by
1,292
References
274
Citations by year
2026: 80 · 2025: 110 · 2024: 107 · 2023: 104 · 2022: 105 · 2021: 97 · 2020: 96 · 2019: 97 · 2018: 86 · 2017: 74 · 2016: 87 · 2015: 75 · 2014: 63 · 2013: 78 · 2012: 30
FWCI
10.62
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
National Institute for Health and Care Research (RP-PG-0606-1045, NF-SI-0509-10229)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
cognitive impairment, mental illness, depression, anxiety, hallucinations, translational research, animal models, cognitive function, quality of life, social and professional integration, cognitive therapy
MeSH terms
Mental Disorders, Brain, Cognition, Cognition Disorders, Humans, Magnetic Resonance Imaging, Neuropsychological Tests, Psychomotor Performance, Risk Factors, Stress, Psychological, Nootropic Agents, Genetic Predisposition to Disease, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.